microRNA-21-IN-1

• CAT Number: I043618
• CAS Number: 2848720-31-8
• Molecular Formula: C30H37FN6O3
• Molecular Weight: 548.65
• Purity: ≥95%
• Synonyms: 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-N-[4-(2-piperidin-1-ylethylcarbamoyl)phenyl]quinoline-3-carboxamide
• InChI: InChI=1S/C30H37FN6O3/c1-2-36-20-24(28(38)23-18-25(31)27(19-26(23)36)37-16-10-32-11-17-37)30(40)34-22-8-6-21(7-9-22)29(39)33-12-15-35-13-4-3-5-14-35/h6-9,18-20,32H,2-5,10-17H2,1H3,(H,33,39)(H,34,40)
• InChIKey: QZVASKUJNDLONM-UHFFFAOYSA-N
• SMILES: CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)NC4=CC=C(C=C4)C(=O)NCCN5CCCCC5

microRNA-21-IN-1（Cat No.:I043618）is a small-molecule inhibitor designed to target microRNA-21 (miR-21), a key regulator involved in the development of various cancers and fibrosis. miR-21 is often upregulated in tumor cells, promoting cell proliferation, survival, and metastasis. By inhibiting miR-21 expression, microRNA-21-IN-1 aims to reverse these processes, making it a promising therapeutic candidate for cancer treatment. It holds potential for reducing tumor growth, enhancing the effectiveness of other cancer therapies, and addressing conditions linked to abnormal miR-21 activity, such as fibrosis and certain cardiovascular diseases.